A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens

Immunity

Volumn 40, Issue 1, 2014, Pages 105-116

  Arora, Pooja ^a   Baena, Andres ^b   Yu, KarlO A ^c   Saini, Neeraj K ^a   Kharkwal, Shalu S ^a   Goldberg, Michael F ^a   Kunnath Velayudhan, Shajo ^a   Carreño, Leandro J ^a,d   Venkataswamy, Manjunatha M ^e   Kim, John ^a   Lazar Molnar, Eszter ^a   Lauvau, Gregoire ^a   Chang, Young tae ^f   Liu, Zheng ^g   Bittman, Robert ^g   Al Shamkhani, Aymen ^h   Cox, Liam R ⁱ   Jervis, Peter J ⁱ   Veerapen, Natacha ⁱ   Besra, Gurdyal S ⁱ   Porcelli, Steven A ^a   more..

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF CHILE   (Chile)

^e NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g CITY UNIVERSITY OF NEW YORK   (United States)

^h UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

ⁱ UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CYTOKINE; GLYCOLIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL COMMUNICATION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE RESPONSE; DENDRITIC CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; ANTIGENS, CD; ANTIGENS, CD1D; ANTIGENS, CD8; CELL COMMUNICATION; CYTOKINES; DENDRITIC CELLS; GALACTOSYLCERAMIDES; GENE EXPRESSION REGULATION; HOMEOSTASIS; INFLAMMATION; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; RECEPTORS, CELL SURFACE;

EID: 84892451751     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2013.12.004     Document Type: Article

References (38)

1. Arora P., Venkataswamy M.M., Baena A., Bricard G., Li Q., Veerapen N., Ndonye R., Park J.J., Lee J.H., Seo K.C., et al. A rapid fluorescence-based assay for classification of iNKT cell activating glycolipids. J.Am. Chem. Soc. 2011, 133:5198-5201.
2. Bai L., Constantinides M.G., Thomas S.Y., Reboulet R., Meng F., Koentgen F., Teyton L., Savage P.B., Bendelac A. Distinct APCs explain the cytokine bias of α-galactosylceramide variants invivo. J.Immunol. 2012, 188:3053-3061.
3. Barral P., Polzella P., Bruckbauer A., van Rooijen N., Besra G.S., Cerundolo V., Batista F.D. CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat. Immunol. 2010, 11:303-312.
4. Barral P., Sánchez-Niño M.D., van Rooijen N., Cerundolo V., Batista F.D. The location of splenic NKT cells favours their rapid activation by blood-borne antigen. EMBO J. 2012, 31:2378-2390.
5. Bezbradica J.S., Stanic A.K., Matsuki N., Bour-Jordan H., Bluestone J.A., Thomas J.W., Unutmaz D., Van Kaer L., Joyce S. Distinct roles of dendritic cells and B cells in Vα14Jα18 natural Tcell activation invivo. J.Immunol. 2005, 174:4696-4705.
6. Boldyrev I.A., Zhai X., Momsen M.M., Brockman H.L., Brown R.E., Molotkovsky J.G. New BODIPY lipid probes for fluorescence studies of membranes. J.Lipid Res. 2007, 48:1518-1532.
7. Brennan P.J., Brigl M., Brenner M.B. Invariant natural killer Tcells: an innate activation scheme linked to diverse effector functions. Nat. Rev. Immunol. 2013, 13:101-117.
8. Bricard G., Venkataswamy M.M., Yu K.O., Im J.S., Ndonye R.M., Howell A.R., Veerapen N., Illarionov P.A., Besra G.S., Li Q., et al. α-Galactosylceramide analogs with weak agonist activity for human iNKT cells define new candidate anti-inflammatory agents. PLoS ONE 2010, 5:e14374.
9. Brigl M., Bry L., Kent S.C., Gumperz J.E., Brenner M.B. Mechanism of CD1d-restricted natural killer Tcell activation during microbial infection. Nat. Immunol. 2003, 4:1230-1237.
10. Brossay L., Jullien D., Cardell S., Sydora B.C., Burdin N., Modlin R.L., Kronenberg M. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J.Immunol. 1997, 159:1216-1224.
11. Carnaud C., Lee D., Donnars O., Park S.H., Beavis A., Koezuka Y., Bendelac A. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J.Immunol. 1999, 163:4647-4650.
12. Forestier C., Takaki T., Molano A., Im J.S., Baine I., Jerud E.S., Illarionov P., Ndonye R., Howell A.R., Santamaria P., et al. Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator. J.Immunol. 2007, 178:1415-1425.
13. Freigang S., Landais E., Zadorozhny V., Kain L., Yoshida K., Liu Y., Deng S., Palinski W., Savage P.B., Bendelac A., Teyton L. Scavenger receptors target glycolipids for natural killer Tcell activation. J.Clin. Invest. 2012, 122:3943-3954.
14. Hildner K., Edelson B.T., Purtha W.E., Diamond M., Matsushita H., Kohyama M., Calderon B., Schraml B.U., Unanue E.R., Diamond M.S., et al. Batf3 deficiency reveals a critical role for CD8α+ dendritic cells in cytotoxic Tcell immunity. Science 2008, 322:1097-1100.
15. Im J.S., Arora P., Bricard G., Molano A., Venkataswamy M.M., Baine I., Jerud E.S., Goldberg M.F., Baena A., Yu K.O., et al. Kinetics and cellular site of glycolipid loading control the outcome of natural killer Tcell activation. Immunity 2009, 30:888-898.
16. Keir M.E., Butte M.J., Freeman G.J., Sharpe A.H. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 2008, 26:677-704.
17. King I.L., Amiel E., Tighe M., Mohrs K., Veerapen N., Besra G., Mohrs M., Leadbetter E.A. The mechanism of splenic invariant NKT cell activation dictates localization invivo. J.Immunol. 2013, 191:572-582.
18. Kinjo Y., Illarionov P., Vela J.L., Pei B., Girardi E., Li X., Li Y., Imamura M., Kaneko Y., Okawara A., et al. Invariant natural killer Tcells recognize glycolipids from pathogenic Gram-positive bacteria. Nat. Immunol. 2011, 12:966-974.
19. Lee W.Y., Moriarty T.J., Wong C.H., Zhou H., Strieter R.M., van Rooijen N., Chaconas G., Kubes P. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat. Immunol. 2010, 11:295-302.
20. Lind S.M., Kuylenstierna C., Moll M., D Jordö E., Winqvist O., Lundeberg L., Karlsson M.A., T Linder M., Johansson C., Scheynius A., et al. IL-18 skews the invariant NKT-cell population via autoreactive activation in atopic eczema. Eur. J. Immunol. 2009, 39:2293-2301.
21. Meyer zum Bueschenfelde C.O., Unternaehrer J., Mellman I., Bottomly K. Regulated recruitment of MHC class II and costimulatory molecules to lipid rafts in dendritic cells. J.Immunol. 2004, 173:6119-6124.
22. Miyamoto K., Miyake S., Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer Tcells. Nature 2001, 413:531-534.
23. Moody D.B., Briken V., Cheng T.Y., Roura-Mir C., Guy M.R., Geho D.H., Tykocinski M.L., Besra G.S., Porcelli S.A. Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat. Immunol. 2002, 3:435-442.
24. Rossjohn J., Pellicci D.G., Patel O., Gapin L., Godfrey D.I. Recognition of CD1d-restricted antigens by natural killer Tcells. Nat. Rev. Immunol. 2012, 12:845-857.
25. Schmieg J., Yang G., Franck R.W., Tsuji M. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer Tcell ligand α-galactosylceramide. J.Exp. Med. 2003, 198:1631-1641.
26. Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 2012, 9:671-675.
27. Singh A.K., Stock P., Akbari O. Role of PD-L1 and PD-L2 in allergic diseases and asthma. Allergy 2011, 66:155-162.
28. Sullivan B.A., Nagarajan N.A., Wingender G., Wang J., Scott I., Tsuji M., Franck R.W., Porcelli S.A., Zajonc D.M., Kronenberg M. Mechanisms for glycolipid antigen-driven cytokine polarization by Vα14i NKT cells. J.Immunol. 2010, 184:141-153.
29. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., Figueiredo J.L., Kohler R.H., Chudnovskiy A., Waterman P., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612-616.
30. Taraban V.Y., Martin S., Attfield K.E., Glennie M.J., Elliott T., Elewaut D., Van Calenbergh S., Linclau B., Al-Shamkhani A. Invariant NKT cells promote CD8+ cytotoxic Tcell responses by inducing CD70 expression on dendritic cells. J.Immunol. 2008, 180:4615-4620.
31. Tyznik A.J., Farber E., Girardi E., Birkholz A., Li Y., Chitale S., So R., Arora P., Khurana A., Wang J., et al. Glycolipids that elicit IFN-γ-biased responses from natural killer Tcells. Chem. Biol. 2011, 18:1620-1630.
32. van den Elzen P., Garg S., León L., Brigl M., Leadbetter E.A., Gumperz J.E., Dascher C.C., Cheng T.Y., Sacks F.M., Illarionov P.A., et al. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 2005, 437:906-910.
33. Venkataswamy M.M., Porcelli S.A. Lipid and glycolipid antigens of CD1d-restricted natural killer Tcells. Semin. Immunol. 2010, 22:68-78.
34. Venkataswamy M.M., Baena A., Goldberg M.F., Bricard G., Im J.S., Chan J., Reddington F., Besra G.S., Jacobs W.R., Porcelli S.A. Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin. J.Immunol. 2009, 183:1644-1656.
35. Wu T.N., Lin K.H., Chang Y.J., Huang J.R., Cheng J.Y., Yu A.L., Wong C.H. Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy. Proc. Natl. Acad. Sci. USA 2011, 108:17275-17280.
36. Yu K.O., Im J.S., Molano A., Dutronc Y., Illarionov P.A., Forestier C., Fujiwara N., Arias I., Miyake S., Yamamura T., et al. Modulation ofCD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides. Proc. Natl. Acad. Sci. USA 2005, 102:3383-3388.
37. Yu K.O., Im J.S., Illarionov P.A., Ndonye R.M., Howell A.R., Besra G.S., Porcelli S.A. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand α-galactosylceramide bound to mouse CD1d. J.Immunol. Methods 2007, 323:11-23.
38. Yu E.D., Girardi E., Wang J., Mac T.T., Yu K.O., Van Calenbergh S., Porcelli S.A., Zajonc D.M. Structural basis for the recognition of C20:2-αGalCer by the invariant NKT TCR-like antibody L363. J Biol Chem. 2011, 287:1269-1278.